UP
koKRtier 1 1분
[신풍제약] 투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인)
No RSS summary is available. Open the original link to read more.
Company
신풍제약· 019170
SHINPOONG PHARMACEUTICAL CO.,LTD
Showing 4 RSS articles and DART filings mapped to this company, sorted by time.
- Market
- LISTED
- Items
- 4
Recent news & filings
UP
koKRtier 1 1분
[신풍제약] 투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인 신청)
No RSS summary is available. Open the original link to read more.
UP
koKRtier 1 1분
[신풍제약] 반기보고서 (2026.06)
No RSS summary is available. Open the original link to read more.
UP
koKRtier 1 1분
[Shinpoong Pharmaceutical] Corporate Governance Report Disclosureko→en
No RSS summary is available. Open the original link to read more.